Chapter 3
LEISHMANIASIS An Overview of New Synthetic Antileishmanial Candidates
Nubia Boechat and Luiz Carlos da Silva Pinheiro
Abstract
Leishmaniasis is considered by the World Health Organization to be one of the world’s most neglected diseases. The current drugs used to treat leishmaniasis were developed more than 40 years ago and are toxic. In addition, they generate resistance, and coinfection with the AIDS virus has worsened the situation of this disease. The purpose of this chapter is to review the various synthetic compounds described between 2002 and 2012 that have been tested against Leishmania spp. and that could be considered possible prototypes for treating this disease. Compounds were organized into 20 chemical classes.
Total Pages: 63-121 (59)
Purchase Chapter
Book Details